Publications
Detailed Information
More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Paick, J-S | - |
dc.contributor.author | Lee, SC | - |
dc.contributor.author | Ku, JH | - |
dc.date.accessioned | 2009-10-20T11:31:39Z | - |
dc.date.available | 2009-10-20T11:31:39Z | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | Prostate Cancer Prostatic Dis 2006; 9: 261-265 | en |
dc.identifier.issn | 1365-7852 (Print) | - |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16683008 | - |
dc.identifier.uri | https://hdl.handle.net/10371/10563 | - |
dc.description.abstract | The objective of this study was to evaluate whether extracorporeal magnetic innervation (ExMI) combined with alpha-blocker therapy is more effective than alpha-blocker monotherapy for patients with non-inflammatory chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS), category IIIB. Patients were randomized to either terazosin monotherapy (group 1, n=21) or terazosin combined with ExMI therapy (group 2, n=19). Patients in group 2 had 12 treatment sessions of ExMI twice a week during 6 weeks. None of the patients experienced any side effects from treatment. The changes in each domain of the National Institutes of Health (NIH)-Chronic Prostatitis Symptom Index (CPSI) measured on week 6 were not significantly different between the groups. However, the difference (median, 25-75th percentiles) between the two groups in total NIH-CPSI scores was -4 (-11.5, -2) for group 1 and -12 (-17.3, -2.3) for group 2, respectively (P=0.047). At 6 weeks, 47.6% (10 of 21) of group 1 had a >25% decrease in total NIH-CPSI compared with 78.9% (15 of 19) of group 2 (P=0.041). Also, more patients in group 2 (78.9%) were rated as responders with a 6-point decrease in NIH-CPSI compared with group 1 (47.6%) (P=0.041). The early results suggest that ExMI combined with alpha-blocker therapy has better effect than alpha-blocker monotherapy for the treatment of CP/CPPS. | en |
dc.language.iso | en | - |
dc.publisher | Nature Publishing Group | en |
dc.subject | prostatitis | en |
dc.subject | pelvic pain | en |
dc.subject | magnetic innervation | en |
dc.subject | drug therapy | en |
dc.title | More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study | en |
dc.type | Article | en |
dc.identifier.doi | 10.1038/sj.pcan.4500881 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.